Author response: Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response
This study utilized mouse models to investigate how endocannabinoids and their receptors influence endometriosis initiation, progression, and immune response, identifying T cell dysfunction in CNR2 knockout models.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This author-response document describes revisions to a study examining how the endocannabinoid system modulates endometriosis lesion initiation, progression, and immune response using endometriosis mouse models and genetic loss-of-function approaches for the canonical receptors CNR1 and CNR2. The reviewed work combines bulk and single-cell RNA sequencing and imaging mass spectrometry/mass cytometry to profile molecular changes and spatial immune-cell alterations in lesions and peritoneal exudate (and splenic) compartments, reporting that CNR1/CNR2 are required for disease processes and T-cell dysfunction, including near absence of CD3+ T cells in CNR2 knockout mice and reduced CD4+ T helper proliferative activity. Limitations raised include lack of detailed lesion burden/histopathology, absence of cell/tissue-specific CNR1/CNR2 interrogation with potential confounds from global knockout effects on reproductive tract physiology or host conditions, and selection of an early 7-day post-induction time point without full rationale. This paper is centrally about endometriosis—specifically, how endocannabinoid receptors CNR1 and CNR2 regulate endometriosis pathogenesis and immune/T-cell responses in mouse models.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
4,958 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Altered differentiation of endometrial mesenchymal stromal fibroblasts is associated with endometriosis susceptibility via openalex
- A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes via openalex
- Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis via openalex
- Endocannabinoids modulate apoptosis in endometriosis and adenomyosis via openalex
- Exacerbation of Endometriosis Due To Regulatory T-Cell Dysfunction via openalex
- Implications of dysregulated endogenous cannabinoid family members in the pathophysiology of endometriosis via openalex
- Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications via openalex
- The dysregulation of leukemia inhibitory factor and its implications for endometriosis pathophysiology via openalex
- The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders via openalex
- T helper (Th)1, Th2, and Th17 interleukin pathways in infertile patients with minimal/mild endometriosis via openalex
- W2898824002 via openalex
- W2909683870 via openalex
- W2911040443 via openalex
- W2924312265 via openalex
- W3091593026 via openalex
- W3135886608 via openalex
- W3157835721 via openalex
- W4211081176 via openalex
- W4281676448 via openalex
- W2790631595 via openalex
- W1969221886 via openalex
- W2035772285 via openalex
- W2076350583 via openalex
- W2082084857 via openalex
- W2087674201 via openalex
- W2119975890 via openalex
- W2123698191 via openalex
- W2460083407 via openalex
- W2532412189 via openalex
- W1886084954 via openalex
- W2884952568 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00